A biomaterial is any substance that has been engineered to interact with biological systems for a medical purpose - either a therapeutic (treat, augment, repair or replace a tissue function of the body) or a diagnostic one. As a science, biomaterials is about fifty years old. Hyaluronic acid (HA) is a substance which is naturally present in the human body with highest concentration in the eye and joints. It has wide applications in the field of osteoarthritis, eye surgery, plastic surgery, prevention of aging etc.
The global Collagen and HA-Based Biomaterials market was valued at US$ 5251 million in 2022 and is anticipated to reach US$ 6837.2 million by 2029, witnessing a CAGR of 3.8% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Geographically, North America holds a leading position with regards to collagen and HA-based biomaterials market followed by the European market. Some of the major factors responsible for the growth of this market in these regions are increasing prevalence of various diseases, development of new and technologically advanced products, use of single-injection visco supplement products, and increasing need of individuals to stay fit and healthy in their advancing years. Asia-Pacific is one of the most lucrative markets for the expansion of collagen and HA-based biomaterials. This region is growing and developing at a rapid pace. The prime reasons which will proliferate the growth of this market in the Asia-Pacific region are high market penetration, increasing demand for tissue regeneration in developing regions, increasing number of elderly people with chronic arthritis due to high population density in countries like China and India, increasing need of individuals to opt for anti-aging treatments in order to enhance their physical appearance, and rising disposable income of the people to spend on sophisticated and advanced technologies.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Collagen and HA-Based Biomaterials, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Collagen and HA-Based Biomaterials.
The Collagen and HA-Based Biomaterials market size, estimations, and forecasts are provided in terms of output/shipments (K MT) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Collagen and HA-Based Biomaterials market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Collagen and HA-Based Biomaterials manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Johnson & Johnson
Alcon Laboratories(US)
Allergan(US)
Anika Therapeutics(US)
Bausch & Lomb(US)
Collagen Solutions Plc. (UK)
Galderma (Switzerland)
Genzyme (US)
Lifecore Biomedical, LLC (US)
Seikagaku Corp. (Japan)
Teijin Pharma Limited (Japan)
Segment by Type
Urinary Incontinence
Corneal Shields
Facial Aesthetic Dermal Fillers
Wound Dressings
Others
Segment by Application
Cosmetology
Wound Care
Others
Production by Region
North America
Europe
China
Japan
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by type, by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Collagen and HA-Based Biomaterials manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Production/output, value of Collagen and HA-Based Biomaterials by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 4: Consumption of Collagen and HA-Based Biomaterials in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 5: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Collagen and HA-Based Biomaterials 麻豆原创 Overview
1.1 Product Definition
1.2 Collagen and HA-Based Biomaterials Segment by Type
1.2.1 Global Collagen and HA-Based Biomaterials 麻豆原创 Value Growth Rate Analysis by Type 2022 VS 2029
1.2.2 Urinary Incontinence
1.2.3 Corneal Shields
1.2.4 Facial Aesthetic Dermal Fillers
1.2.5 Wound Dressings
1.2.6 Others
1.3 Collagen and HA-Based Biomaterials Segment by Application
1.3.1 Global Collagen and HA-Based Biomaterials 麻豆原创 Value Growth Rate Analysis by Application: 2022 VS 2029
1.3.2 Cosmetology
1.3.3 Wound Care
1.3.4 Others
1.4 Global 麻豆原创 Growth Prospects
1.4.1 Global Collagen and HA-Based Biomaterials Production Value Estimates and Forecasts (2018-2029)
1.4.2 Global Collagen and HA-Based Biomaterials Production Capacity Estimates and Forecasts (2018-2029)
1.4.3 Global Collagen and HA-Based Biomaterials Production Estimates and Forecasts (2018-2029)
1.4.4 Global Collagen and HA-Based Biomaterials 麻豆原创 Average Price Estimates and Forecasts (2018-2029)
1.5 Assumptions and Limitations
2 麻豆原创 Competition by Manufacturers
2.1 Global Collagen and HA-Based Biomaterials Production 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Collagen and HA-Based Biomaterials Production Value 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Key Players of Collagen and HA-Based Biomaterials, Industry Ranking, 2021 VS 2022 VS 2023
2.4 Global Collagen and HA-Based Biomaterials 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.5 Global Collagen and HA-Based Biomaterials Average Price by Manufacturers (2018-2023)
2.6 Global Key Manufacturers of Collagen and HA-Based Biomaterials, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Collagen and HA-Based Biomaterials, Product Offered and Application
2.8 Global Key Manufacturers of Collagen and HA-Based Biomaterials, Date of Enter into This Industry
2.9 Collagen and HA-Based Biomaterials 麻豆原创 Competitive Situation and Trends
2.9.1 Collagen and HA-Based Biomaterials 麻豆原创 Concentration Rate
2.9.2 Global 5 and 10 Largest Collagen and HA-Based Biomaterials Players 麻豆原创 Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Collagen and HA-Based Biomaterials Production by Region
3.1 Global Collagen and HA-Based Biomaterials Production Value Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.2 Global Collagen and HA-Based Biomaterials Production Value by Region (2018-2029)
3.2.1 Global Collagen and HA-Based Biomaterials Production Value 麻豆原创 Share by Region (2018-2023)
3.2.2 Global Forecasted Production Value of Collagen and HA-Based Biomaterials by Region (2024-2029)
3.3 Global Collagen and HA-Based Biomaterials Production Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
3.4 Global Collagen and HA-Based Biomaterials Production by Region (2018-2029)
3.4.1 Global Collagen and HA-Based Biomaterials Production 麻豆原创 Share by Region (2018-2023)
3.4.2 Global Forecasted Production of Collagen and HA-Based Biomaterials by Region (2024-2029)
3.5 Global Collagen and HA-Based Biomaterials 麻豆原创 Price Analysis by Region (2018-2023)
3.6 Global Collagen and HA-Based Biomaterials Production and Value, Year-over-Year Growth
3.6.1 North America Collagen and HA-Based Biomaterials Production Value Estimates and Forecasts (2018-2029)
3.6.2 Europe Collagen and HA-Based Biomaterials Production Value Estimates and Forecasts (2018-2029)
3.6.3 China Collagen and HA-Based Biomaterials Production Value Estimates and Forecasts (2018-2029)
3.6.4 Japan Collagen and HA-Based Biomaterials Production Value Estimates and Forecasts (2018-2029)
4 Collagen and HA-Based Biomaterials Consumption by Region
4.1 Global Collagen and HA-Based Biomaterials Consumption Estimates and Forecasts by Region: 2018 VS 2022 VS 2029
4.2 Global Collagen and HA-Based Biomaterials Consumption by Region (2018-2029)
4.2.1 Global Collagen and HA-Based Biomaterials Consumption by Region (2018-2023)
4.2.2 Global Collagen and HA-Based Biomaterials Forecasted Consumption by Region (2024-2029)
4.3 North America
4.3.1 North America Collagen and HA-Based Biomaterials Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.3.2 North America Collagen and HA-Based Biomaterials Consumption by Country (2018-2029)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Collagen and HA-Based Biomaterials Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.4.2 Europe Collagen and HA-Based Biomaterials Consumption by Country (2018-2029)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Collagen and HA-Based Biomaterials Consumption Growth Rate by Region: 2018 VS 2022 VS 2029
4.5.2 Asia Pacific Collagen and HA-Based Biomaterials Consumption by Region (2018-2029)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Collagen and HA-Based Biomaterials Consumption Growth Rate by Country: 2018 VS 2022 VS 2029
4.6.2 Latin America, Middle East & Africa Collagen and HA-Based Biomaterials Consumption by Country (2018-2029)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
5 Segment by Type
5.1 Global Collagen and HA-Based Biomaterials Production by Type (2018-2029)
5.1.1 Global Collagen and HA-Based Biomaterials Production by Type (2018-2023)
5.1.2 Global Collagen and HA-Based Biomaterials Production by Type (2024-2029)
5.1.3 Global Collagen and HA-Based Biomaterials Production 麻豆原创 Share by Type (2018-2029)
5.2 Global Collagen and HA-Based Biomaterials Production Value by Type (2018-2029)
5.2.1 Global Collagen and HA-Based Biomaterials Production Value by Type (2018-2023)
5.2.2 Global Collagen and HA-Based Biomaterials Production Value by Type (2024-2029)
5.2.3 Global Collagen and HA-Based Biomaterials Production Value 麻豆原创 Share by Type (2018-2029)
5.3 Global Collagen and HA-Based Biomaterials Price by Type (2018-2029)
6 Segment by Application
6.1 Global Collagen and HA-Based Biomaterials Production by Application (2018-2029)
6.1.1 Global Collagen and HA-Based Biomaterials Production by Application (2018-2023)
6.1.2 Global Collagen and HA-Based Biomaterials Production by Application (2024-2029)
6.1.3 Global Collagen and HA-Based Biomaterials Production 麻豆原创 Share by Application (2018-2029)
6.2 Global Collagen and HA-Based Biomaterials Production Value by Application (2018-2029)
6.2.1 Global Collagen and HA-Based Biomaterials Production Value by Application (2018-2023)
6.2.2 Global Collagen and HA-Based Biomaterials Production Value by Application (2024-2029)
6.2.3 Global Collagen and HA-Based Biomaterials Production Value 麻豆原创 Share by Application (2018-2029)
6.3 Global Collagen and HA-Based Biomaterials Price by Application (2018-2029)
7 Key Companies Profiled
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Collagen and HA-Based Biomaterials Corporation Information
7.1.2 Johnson & Johnson Collagen and HA-Based Biomaterials Product Portfolio
7.1.3 Johnson & Johnson Collagen and HA-Based Biomaterials Production, Value, Price and Gross Margin (2018-2023)
7.1.4 Johnson & Johnson Main Business and 麻豆原创s Served
7.1.5 Johnson & Johnson Recent Developments/Updates
7.2 Alcon Laboratories(US)
7.2.1 Alcon Laboratories(US) Collagen and HA-Based Biomaterials Corporation Information
7.2.2 Alcon Laboratories(US) Collagen and HA-Based Biomaterials Product Portfolio
7.2.3 Alcon Laboratories(US) Collagen and HA-Based Biomaterials Production, Value, Price and Gross Margin (2018-2023)
7.2.4 Alcon Laboratories(US) Main Business and 麻豆原创s Served
7.2.5 Alcon Laboratories(US) Recent Developments/Updates
7.3 Allergan(US)
7.3.1 Allergan(US) Collagen and HA-Based Biomaterials Corporation Information
7.3.2 Allergan(US) Collagen and HA-Based Biomaterials Product Portfolio
7.3.3 Allergan(US) Collagen and HA-Based Biomaterials Production, Value, Price and Gross Margin (2018-2023)
7.3.4 Allergan(US) Main Business and 麻豆原创s Served
7.3.5 Allergan(US) Recent Developments/Updates
7.4 Anika Therapeutics(US)
7.4.1 Anika Therapeutics(US) Collagen and HA-Based Biomaterials Corporation Information
7.4.2 Anika Therapeutics(US) Collagen and HA-Based Biomaterials Product Portfolio
7.4.3 Anika Therapeutics(US) Collagen and HA-Based Biomaterials Production, Value, Price and Gross Margin (2018-2023)
7.4.4 Anika Therapeutics(US) Main Business and 麻豆原创s Served
7.4.5 Anika Therapeutics(US) Recent Developments/Updates
7.5 Bausch & Lomb(US)
7.5.1 Bausch & Lomb(US) Collagen and HA-Based Biomaterials Corporation Information
7.5.2 Bausch & Lomb(US) Collagen and HA-Based Biomaterials Product Portfolio
7.5.3 Bausch & Lomb(US) Collagen and HA-Based Biomaterials Production, Value, Price and Gross Margin (2018-2023)
7.5.4 Bausch & Lomb(US) Main Business and 麻豆原创s Served
7.5.5 Bausch & Lomb(US) Recent Developments/Updates
7.6 Collagen Solutions Plc. (UK)
7.6.1 Collagen Solutions Plc. (UK) Collagen and HA-Based Biomaterials Corporation Information
7.6.2 Collagen Solutions Plc. (UK) Collagen and HA-Based Biomaterials Product Portfolio
7.6.3 Collagen Solutions Plc. (UK) Collagen and HA-Based Biomaterials Production, Value, Price and Gross Margin (2018-2023)
7.6.4 Collagen Solutions Plc. (UK) Main Business and 麻豆原创s Served
7.6.5 Collagen Solutions Plc. (UK) Recent Developments/Updates
7.7 Galderma (Switzerland)
7.7.1 Galderma (Switzerland) Collagen and HA-Based Biomaterials Corporation Information
7.7.2 Galderma (Switzerland) Collagen and HA-Based Biomaterials Product Portfolio
7.7.3 Galderma (Switzerland) Collagen and HA-Based Biomaterials Production, Value, Price and Gross Margin (2018-2023)
7.7.4 Galderma (Switzerland) Main Business and 麻豆原创s Served
7.7.5 Galderma (Switzerland) Recent Developments/Updates
7.8 Genzyme (US)
7.8.1 Genzyme (US) Collagen and HA-Based Biomaterials Corporation Information
7.8.2 Genzyme (US) Collagen and HA-Based Biomaterials Product Portfolio
7.8.3 Genzyme (US) Collagen and HA-Based Biomaterials Production, Value, Price and Gross Margin (2018-2023)
7.8.4 Genzyme (US) Main Business and 麻豆原创s Served
7.7.5 Genzyme (US) Recent Developments/Updates
7.9 Lifecore Biomedical, LLC (US)
7.9.1 Lifecore Biomedical, LLC (US) Collagen and HA-Based Biomaterials Corporation Information
7.9.2 Lifecore Biomedical, LLC (US) Collagen and HA-Based Biomaterials Product Portfolio
7.9.3 Lifecore Biomedical, LLC (US) Collagen and HA-Based Biomaterials Production, Value, Price and Gross Margin (2018-2023)
7.9.4 Lifecore Biomedical, LLC (US) Main Business and 麻豆原创s Served
7.9.5 Lifecore Biomedical, LLC (US) Recent Developments/Updates
7.10 Seikagaku Corp. (Japan)
7.10.1 Seikagaku Corp. (Japan) Collagen and HA-Based Biomaterials Corporation Information
7.10.2 Seikagaku Corp. (Japan) Collagen and HA-Based Biomaterials Product Portfolio
7.10.3 Seikagaku Corp. (Japan) Collagen and HA-Based Biomaterials Production, Value, Price and Gross Margin (2018-2023)
7.10.4 Seikagaku Corp. (Japan) Main Business and 麻豆原创s Served
7.10.5 Seikagaku Corp. (Japan) Recent Developments/Updates
7.11 Teijin Pharma Limited (Japan)
7.11.1 Teijin Pharma Limited (Japan) Collagen and HA-Based Biomaterials Corporation Information
7.11.2 Teijin Pharma Limited (Japan) Collagen and HA-Based Biomaterials Product Portfolio
7.11.3 Teijin Pharma Limited (Japan) Collagen and HA-Based Biomaterials Production, Value, Price and Gross Margin (2018-2023)
7.11.4 Teijin Pharma Limited (Japan) Main Business and 麻豆原创s Served
7.11.5 Teijin Pharma Limited (Japan) Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Collagen and HA-Based Biomaterials Industry Chain Analysis
8.2 Collagen and HA-Based Biomaterials Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Collagen and HA-Based Biomaterials Production Mode & Process
8.4 Collagen and HA-Based Biomaterials Sales and 麻豆原创ing
8.4.1 Collagen and HA-Based Biomaterials Sales Channels
8.4.2 Collagen and HA-Based Biomaterials Distributors
8.5 Collagen and HA-Based Biomaterials Customers
9 Collagen and HA-Based Biomaterials 麻豆原创 Dynamics
9.1 Collagen and HA-Based Biomaterials Industry Trends
9.2 Collagen and HA-Based Biomaterials 麻豆原创 Drivers
9.3 Collagen and HA-Based Biomaterials 麻豆原创 Challenges
9.4 Collagen and HA-Based Biomaterials 麻豆原创 Restraints
10 Research Finding and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 麻豆原创 Size Estimation
11.1.3 麻豆原创 Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
Johnson & Johnson
Alcon Laboratories(US)
Allergan(US)
Anika Therapeutics(US)
Bausch & Lomb(US)
Collagen Solutions Plc. (UK)
Galderma (Switzerland)
Genzyme (US)
Lifecore Biomedical, LLC (US)
Seikagaku Corp. (Japan)
Teijin Pharma Limited (Japan)
听
听
*If Applicable.
